Pharmaceutical Pricing & Distribution in Japan, 2012 Update

About This Presentation
Title:

Pharmaceutical Pricing & Distribution in Japan, 2012 Update

Description:

Pharmaceutical Pricing & Distribution in Japan, 2012 Update – PowerPoint PPT presentation

Number of Views:210

less

Transcript and Presenter's Notes

Title: Pharmaceutical Pricing & Distribution in Japan, 2012 Update


1

Introduction Aarkstore Enterprise
Our comprehensive and wide range of databank in
the field of Market Research Report provides
exclusive, pioneering and innovative service to
our report buyers. Our high-quality databank
comprises of company profiles, strategy review,
company report, industry reports, company
financials, industry research, SWOT analysis, and
so on Aarkstore.com is in the forefront as it
is enriched with comprehensive informative and
interactive search features. One can browse to
have ample access of beyond 2.5 lakh business
industry reports.
2
Category
  • Pharmaceuticals Healthcare Market Research
    Reports http//www.aarkstore.co
    m/market-sector-reports/Pharmaceuticals--Healthca
    re-7.html

3
Report
2013 Pharmaceutical Pricing Distribution in
Japan, 2012 Update Aarkstore.in
http//aarkstore.in/Pharmaceutical-Pricing-Dist
ribution-in-Japan-2012-Update.html
4
Request Sample
http//www.aarkstore.com/Report/SampleRequest.asp?
RptId91583
5
Summary
  • No serious pharmaceutical company can
    afford to ignore Japan, a 120 billion market,
    the second-largest in the world. Nevertheless, it
    remains a tough and highly competitive market to
    crack, with the environment for developing and
    marketing medicines dominated by price. No new
    brand can be introduced without a yakka
    (reimbursement price) set by the government.
    Innovative drugs receive price premiums while
    others are capped at the price of older entrants.
    Discounting to the trade is inescapable, but is
    punished by downward price revisions on a scale
    and frequency unseen elsewhere. Big selling
    brands are repriced. Distribution is inherently
    linked to the pricing process and is particularly
    opaque to outsiders.



    More

6
Table of Contents
  • Executive Summary   1. Market
    Overview 1.1 Healthcare System  1.2 Leading
    Companies, 2011 1.3 RD 1.4 Sales and
    Marketing 1.5 Leading Products, 2011  1.6
    Foreign Exchange Rates  2. Market Access 2.1
    Compassionate Use 2.2. Launch Principles and
    Timings  2.3 Reimbursement Coverage
    More

7
Latest Reports
http//www.aarkstore.com/publishers/JustPharmaRe
ports-12.htmlRisk Sharing and Other Forms of
Managed Entry Agreements for Medicines,
Worldwide  Pharmaceutical Pricing
Distribution in Japan, 2012 Update  Biosimilars
Current Situation Future Prospects,
Worldwide  Orphan Drugs in Europe Pricing,
Reimbursement, Funding Market Access Issues,
2011 Edition  Market Access Korea Breaking
into the Developed Worlds Fastest Growing
Pharmaceutical Market
8
(No Transcript)
9
Contact us
For More details about above other Reports
please contact Lavanya Aarkstore.com Contact
Marketing team Mob.No.918149852585 Email
Customersupport_at_aarkstore.com URL
http//www.aarkstore.com
http//aarkstore.in/
Write a Comment
User Comments (0)